Literature DB >> 33781445

A Novel Intergenic Region Between KLHL31 and LRRC1-ALK Exon 20 Fusion Variant in Advanced Lung Adenocarcinoma and its Remarkable Response to ALK Inhibitor.

Huibing Qiu1, Qianwen Li2, Yajie Xiao3, Dongfang Wu3, Rui Meng4.   

Abstract

Entities:  

Year:  2021        PMID： 33781445     DOI： 10.1016/j.jtho.2020.12.016

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

1.  Characterizing kinase intergenic-breakpoint rearrangements in a large-scale lung cancer population and real-world clinical outcomes.

Authors:  Y Yao; Z Yu; Y Ma; Q Ou; X Wu; D Lu; X Li
Journal:  ESMO Open       Date:  2022-03-16

2.  Identification of a novel RMST-ALK rearrangement in advanced lung adenocarcinoma and durable response to ceritinib: A case report.

Authors:  Hui Li; Yixiao Deng; Bin Chen; Yajie Xiao; Jie Yang; Qionghui Liu; Gengpeng Lin
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.